Depression and anxiety in the practice of cardiology

Kardiologia Polska

Volumn 71, Issue 8, 2013, Pages 781-786

  Dudek, Dominika ^a,b,c   Jaeschke, Rafal ^a,b   Styczeń, Krzysztof ^a,c   Pilecki, Maciej ^a,d  

^a UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c INSTITUTE OF PHARMACOLOGY   (Poland)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ANXIETY DISORDER; BLOOD PRESSURE; CARDIOLOGY; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DEPRESSION; DISEASE COURSE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC HEART DISEASE; PROGNOSIS; REVIEW;

EID: 84884395313     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.2013.0188     Document Type: Review

References (52)

1. Kessler RC, Berglund P, Demler O et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 2005; 62: 593-602. (Pubitemid 40973434)
2. Schoevers RA, Van HL, Koppelmans V et al. Managing the patient with co-morbid depression and an anxiety disorder. Drugs, 2008; 68: 1621-1634.
3. Dudek D, Siwek M. Wspólistnienie chorób somatycznych i depresji. Psychiatria, 2007; 4: 17-24.
4. Thombs BD, Bass EB, Ford DE et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med, 2006; 21: 30-38.
5. Diez-Quevedo C, Lupon J, Gonzalez B et al. Depression, antidepressants, and long-term mortality in heart failure. Int J Cardiol, 2012 [Epub ahead of print 2012/04/18].
6. Dudek D, Sobanski JA. Mental disorders in somatic diseases: psychopathology and treatment. Pol Arch Med Wewn, 2012; 122: 624-629.
7. Shah AJ, Veledar E, Hong Y et al. Depression and history of attempted suicide as risk factors for heart disease mortality in young individuals. Arch Gen Psychiatry, 2011; 68: 1135-1142.
8. Mavrides N, Nemeroff C. Treatment of depression in cardiovascular disease. Depress Anxiety, 2013 [Epub ahead of print 2013/01/08].
9. Nair N, Farmer C, Gongora E, Dehmer GJ. Commonality between depression and heart failure. Am J Cardiol, 2012; 109: 768-772.
10. Khaled SM, Bulloch AG, Williams JV et al. Persistent heavy smoking as risk factor for major depression (MD) incidence: evidence from a longitudinal Canadian cohort of the National Population Health Survey. J Psychiatr Res, 2012; 46: 436-443.
11. Potoczek A. Zwia̧zek mechanizmów obronnych osobowości z nasileniem objawów zespolu lȩku napadowego i depresji u kobiet i mȩ?czyzn z astma̧cie?ka̧i trudna̧oraz astma̧aspirynowa̧. Psychiatr Pol, 2011; 45: 21-33.
12. Duda-Sobczak A, Wierusz-Wysocka B. Cukrzyca a choroby psychiczne. Psychiatr Pol, 2011; 45: 589-598.
13. Jaeschke R. B? i depresja w chorobach nowotworowych. In: Dudek D ed. B? i depresja. Termedia, Poznań 2011: 103-118.
14. Makara-Studzińska M, Ksia̧?ek P, Koslak A et al. Rozpowszechnienie zaburzeń depresyjnych wśród pacjentów ze schylkowa̧niewydolnościa̧nerek. Psychiatr Pol, 2011; 45: 187-195.
15. Celińska-Lowenhoff M, Musial J. Zaburzenia psychiczne w chorobach autoimmunologicznych: problemy diagnostyczno-terapeutyczne. Psychiatr Pol, 2012; 46: 1029-1042.
16. Celano CM, Huffman JC. Depression and cardiac disease: a review. Cardiol Rev, 2011; 19: 130-142.
17. Hallas CN, Wray J, Andreou P, Banner NR. Depression and perceptions about heart failure predict quality of life in patients with advanced heart failure. Heart Lung, 2011; 40: 111-121.
18. Moser DK. "The rust of life": impact of anxiety on cardiac patients. Am J Crit Care, 2007; 16: 361-369.
19. De Jong MJ, Chung ML, Roser LP et al. A five-country comparison of anxiety early after acute myocardial infarction. Eur J Cardiovasc Nurs, 2004; 3: 129-134. (Pubitemid 38968425)
20. Martens EJ, Hoen PW, Mittelhaeuser M et al. Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med, 2010; 40: 807-814.
21. de Jonge P, Mangano D, Whooley MA. Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Psychosom Med, 2007; 69: 735-739. (Pubitemid 350287480)
22. de Jonge P, Denollet J, van Melle JP et al. Associations of type-D personality and depression with somatic health in myocardial infarction patients. J Psychosom Res, 2007; 63: 477-482. (Pubitemid 350007662)
23. Frasure-Smith N, Lesperance F, Habra M et al. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation, 2009; 120: 134-140.
24. Rutledge T, Reis VA, Linke SE et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol, 2006; 48: 1527-1537. (Pubitemid 44528168)
25. Jiang W, Kuchibhatla M, Clary GL et al. Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J, 2007; 154: 102-108. (Pubitemid 46920483)
26. Verbeek DE, van Riezen J, de Boer RA et al. A review on the putative association between beta-blockers and depression. Heart Fail Clin, 2011; 7: 89-99.
27. Loftis JM, Patterson AL, Wilhelm CJ et al. Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study. J Psychosom Res, 2013; 74: 57-63.
28. Rackley S, Bostwick JM. Depression in medically ill patients. Psychiatr Clin North Am, 2012; 35: 231-247.
29. Freedenberg V, Thomas SA, Friedmann E. Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review. Heart Fail Clin, 2011; 7: 59-68.
30. Thomas SA, Friedmann E, Kao CW et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care, 2006; 15: 389-398. (Pubitemid 44859179)
31. Trotter R, Gallagher R, Donoghue J. Anxiety in patients undergoing percutaneous coronary interventions. Heart Lung, 2011; 40: 185-192.
32. Pawlak A, Krejca M, Janas-Kozik M et al. Ocena lȩku i depresji w okresie okolooperacyjnym u pacjentów poddawanych rewaskularyzacji miȩśnia sercowego. Psychiatr Pol, 2012; 46: 63-74.
33. Szwed K, Bieliński M, Dro?d? W et al. Zaburzenia funkcjonowania poznawczego po zabiegach kardiochirurgicznych. Psychiatr Pol, 2012; 46: 473-482.
34. Freedland KE, Skala JA, Carney RM et al. Treatment of depression after coronary artery bypass surgery: a randomized controlled trial. Arch Gen Psychiatry, 2009; 66: 387-396.
35. Potoczek A. Ogólne ró?nice w nasileniu katastroficznej interpretacji doznań somatycznych oraz jej szczególowy zwia̧zek z nasileniem objawów zespolu lȩku napadowego i depresji u ko-biet i mȩ?czyzn z astma̧ciȩ?ka̧i trudna̧oraz astma̧aspirynowa̧Psychiatr Pol 2011 45 481-493.
36. Lichtman JH, Bigger JT, Jr., Blumenthal JA et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation, 2008; 118: 1768-1775.
37. Ramasubbu R, Beaulieu S, Taylor VH et al. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid medical conditions: diagnostic, assessment, and treatment principles. Ann Clin Psychiatry, 2012; 24: 82-90.
38. Dudek D, Siwek M, Wysocki H. Depresja a choroba niedokrwienna serca. In: Podolec P ed. Podrȩcznik Polskiego Forum Profilaktyki. Tom II. Medycyna Praktyczna, Kraków 2010: 503-510.
39. Tomaszewski K, Zarychta M, Bieńkowska A et al. Walidacja polskiej wersji jȩzykowej Patient Health Questionnaire-9 w populacji hospitalizowanych osób starszych. Psychiatr Pol, 2011; 45: 223-233.
40. Wichowicz HM, Wieczorek D. Badanie przesiewowe depresji poudarowej z u?yciem Hospital Anxiety and Depression Scale (HADS). Psychiatr Pol, 2011; 45: 505-514.
41. Albiński R, Kleszczewska-Albińska A, Bedyńska S. Geriatryczna Skala Depresji (GDS). Trafność i rzetelnoś ć ró?nych wersji tego narzȩdzia: przegla̧d badań. Psychiatr Pol, 2011; 45: 555-562.
42. Davidson KW, Kupfer DJ, Bigger JT et al. Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med, 2006; 68: 645-650. (Pubitemid 44454630)
43. Talarowska M, Florkowski A, Zboralski K, Galecki P. Wykonanie testu pamiȩci wzrokowej Bentona oraz Wzrokowo-Motorycznego Testu Gestalt Lauretty Bender przez osoby z depresja̧i organicznymi zaburzeniami depresyjnymi. Psychiatr Pol, 2011; 45: 495-504.
44. Talarowska M, Zboralski K, Mossakowska-Wojcik J, Galecki P. Wykonanie Testu Laczenia Punktów przez osoby z depresja̧i organicznymi zaburzeniami depresyjnymi. Psychiatr Pol, 2012; 46: 273-282.
45. Chochinov HM, Wilson KG, Enns M, Lander S. "Are you depressed?" Screening for depression in the terminally ill. Am J Psychiatry, 1997; 154: 674-676. (Pubitemid 27198318)
46. Thombs BD, de Jonge P, Coyne JC et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA, 2008; 300: 2161-2171.
47. Thombs BD, Roseman M, Coyne JC et al. Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review. PLoS One, 2013; 8: e52654.
48. Jaeschke R, Siwek M, Brozek J, Brudkiewicz P. Badania z randomizacja̧w psychiatrii. Psychiatr Pol, 2012; 46: 109-121.
49. Ramasubbu R, Taylor VH, Samaan Z et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry, 2012; 24: 91-109.
50. Dudek D, Siwek M. Leczenie zaburzeń depresyjnych u pacjentów z chorobami ukladu sercowo-naczyniowego. In: Podolec P ed. Podrȩcznik Polskiego Forum Profilaktyki. Tom II. Medycyna Praktyczna, Kraków 2010: 547-554.
51. Honkola J, Hookana E, Malinen S et al. Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. Eur Heart J, 2012; 33: 745-751.
52. Wang JT, Hoffman B, Blumenthal JA. Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients. Expert Opin Pharmacother, 2011; 12: 85-98.